Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a highly potent therapeutic agent that has been shown to significantly increase the apoptosis as well as decrease the migration capacity of GBM cells [17, 18]. Here, TNFSF10 is linked to glioblastoma.